IM Primary vaccination: 3 doses in the 1st 6 mth of life & can start from the age of 6 wk. Booster dose: Recommended in the 2nd yr of life. Infant 6-12 mth previously unvaccinated 2 inj w/ an interval of 1 mth then booster in 2nd yr of life. Previously unvaccinated childn 1-5 yr 1 dose.
Do not administer IV. Postpone vaccination in subjects suffering from acute severe febrile illness. Anaphylactic event following administration. Not a substitute for routine tetanus vaccination. Administer SC to subjects w/ thrombocytopenia or a bleeding disorder. Potential risk of apnoea & the need for resp monitoring for 48-72 hr should be considered in very premature infants (≤28 wk of gestation) & those w/ history of resp immaturity. Patients w/ immunodeficiency. Antigen detection may not have a diagnostic value in suspected Hib disease w/in 1-2 wk of vaccination. Not intended for use in adults.
Can be mixed in the same syringe w/ GSK vaccine Infanrix (DTPa vaccine). Other inj vaccines should always be administered at different inj sites. Response may not be adequately achieved if given w/ immunosuppressive therapy.
Sign Out
